SECTION 2

Effective regulatory strategies

Regulatory agencies worldwide are facing a sharp increase in complex cell and gene therapy product applications, making it harder for them to give companies timely advice and guidance. In this section, Parexel experts and former regulators share how greater self-reliance and thorough preparation can help companies avoid delays and setbacks.

Download the executive summary of the full report